Immunogen Inc. (IMGN) PT Raised to $20 at Barclays, 'KOL commentary suggested the drug is likely practice changing'
Tweet Send to a Friend
(Updated - June 9, 2023 9:06 AM EDT)
Barclays analyst Peter Lawson raised the price ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Barclays analyst Peter Lawson raised the price ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
